GE HealthCare Technologies Inc.
GEHCHealthcare
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Oct 28, 2026
Next reportFebruary 8, 2027pre-market · forecast 1.584 $/share
Revenue
$5.51B
▲ +7.2% vs prior year YoY
Net income
$615.00M
▲ +37.9% vs prior year YoY
EPS
1.36$
▲ +38.8% vs prior year YoY
Net margin
11.2%
▲ +2.5 pp vs prior year YoY
Revenue▲ +7.2%
Margins (% of revenue)GrossOperatingNet
Net income▲ +37.9%
EPS▲ +38.8%
Financial statements
View 10-Q filed October 28, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $5.32B | $4.78B | $5.01B | $5.14B | $5.70B | $5.13B | $5.29B | $5.51B | ▲ +7.2% |
| Gross profit | $2.27B | $2.01B | $1.99B | $1.99B | $2.26B | $1.98B | $2.18B | $2.22B | ▲ +11.8% |
| Operating income | $801.00M | $629.00M | $654.00M | $653.00M | $827.00M | $515.00M | $739.00M | $805.00M | ▲ +23.3% |
| Net income | $721.00M | $564.00M | $486.00M | $446.00M | $588.00M | $389.00M | $561.00M | $615.00M | ▲ +37.9% |
| R&D | $344.00M | $344.00M | $302.00M | $292.00M | $322.00M | $345.00M | $323.00M | $320.00M | ▲ +9.6% |
| EPS (diluted) | — | 1.23 $ | 1.06 $ | 0.98 $ | — | 0.85 $ | 1.24 $ | 1.36 $ | ▲ +38.8% |
| Margins (% of revenue) | |||||||||
| Gross | 42.8 % | 42.1 % | 39.6 % | 38.7 % | 39.7 % | 38.5 % | 41.2 % | 40.3 % | ▲ +1.6 pt |
| Operating | 15.1 % | 13.2 % | 13.1 % | 12.7 % | 14.5 % | 10.0 % | 14.0 % | 14.6 % | ▲ +1.9 pt |
| Net | 13.6 % | 11.8 % | 9.7 % | 8.7 % | 10.3 % | 7.6 % | 10.6 % | 11.2 % | ▲ +2.5 pt |
| Balance sheet | |||||||||
| Assets | $33.09B | $33.59B | $35.50B | $36.13B | $36.91B | $37.13B | $37.25B | $38.37B | ▲ +6.2% |
| Liabilities | $24.44B | $24.17B | $25.55B | $25.91B | $26.31B | $26.23B | $26.03B | $26.51B | ▲ +2.3% |
| Equity | $8.46B | $9.21B | $9.73B | $10.02B | $10.39B | $10.68B | $10.99B | $11.63B | ▲ +16.1% |
| Cash | $2.87B | $2.45B | $3.74B | $4.00B | $4.49B | $2.26B | $2.08B | $2.83B | ▼ -29.4% |
| Capital | |||||||||
| Shares outstanding | 457.30M | 457.88M | 456.56M | 455.52M | 455.75M | 454.89M | 451.69M | 452.14M | ▼ -0.7% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.